Jinghua Yan to Coronavirus Infections
This is a "connection" page, showing publications Jinghua Yan has written about Coronavirus Infections.
Connection Strength
0.083
-
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
Score: 0.028
-
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 2015 Nov; 25(11):1237-49.
Score: 0.020
-
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Cell. 2020 08 06; 182(3):722-733.e11.
Score: 0.007
-
Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells. J Biol Chem. 2018 07 27; 293(30):11709-11726.
Score: 0.006
-
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice. Antiviral Res. 2017 04; 140:55-61.
Score: 0.005
-
Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model. Antiviral Res. 2017 01; 137:125-130.
Score: 0.005
-
MERS-CoV spike protein: Targets for vaccines and therapeutics. Antiviral Res. 2016 09; 133:165-77.
Score: 0.005
-
Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe. 2014 Sep 10; 16(3):328-37.
Score: 0.005
-
Particulate Alum via Pickering Emulsion for an Enhanced COVID-19 Vaccine Adjuvant. Adv Mater. 2020 Oct; 32(40):e2004210.
Score: 0.002